Skip to main content

Novavax, Emergent BioSolutions Expand Partnership to Include Flu Vaccine

Maryland biotech companies Emergent BioSolutions Inc. and Novavax have expanded their partnership to include production of an influenza vaccine. Emergent will guide the NanoFlu vaccine to the commercial manufacturing stage at its Bayview location in Baltimore City, according to the Baltimore Business Journal. This comes just weeks after the two companies announced a partnership to develop a COVID-19 vaccine.

Read More

Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927